Literature DB >> 8470835

Emergency cardiac stress testing in the evaluation of emergency department patients with atypical chest pain.

J R Kerns1, T F Shaub, P B Fontanarosa.   

Abstract

STUDY
OBJECTIVES: To determine the feasibility, safety, and reliability of emergency cardiac treadmill exercise stress testing (CTEST) in the evaluation of emergency department patients with atypical chest pain.
DESIGN: Thirty-two patients with atypical chest pain, normal ECGs, and risk factor stratification having low-probability of coronary artery disease were evaluated prospectively using outpatient, emergency CTEST. Study patients were compared with a retrospectively selected sample of admitted patients diagnosed with atypical chest pain who met the study criteria and were evaluated with CTEST as inpatients. All patients had follow-up at three and six months after evaluation.
SETTING: University-affiliated community teaching hospital with 65,000 annual ED visits.
RESULTS: All patients had normal CTEST. No patient had evidence of coronary artery disease, myocardial infarction, or sudden death during the follow-up period. The average length of stay was 5.5 hours for emergency CTEST patients versus two days for inpatients. The average patient charge was $467 for ED evaluation with emergency CTEST versus $2,340 for inpatient evaluation.
CONCLUSION: Emergency CTEST is a safe, efficient, cost-effective, and practical method of evaluating selected ED patients with chest pain. It is a useful aid for clinical decision making and may help to prevent unnecessary hospital admissions.

Entities:  

Mesh:

Year:  1993        PMID: 8470835     DOI: 10.1016/s0196-0644(05)80793-0

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  9 in total

Review 1.  Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. British Cardiac Society Guidelines and Medical Practice Committee and Royal College of Physicians Clinical Effectiveness and Evaluation Unit.

Authors: 
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

2.  Chest pain evaluation units

Authors: 
Journal:  West J Med       Date:  2000-12

Review 3.  Accident and emergency medicine.

Authors:  S A Stahmer
Journal:  BMJ       Date:  1998-04-04

4.  A prospective, observational study of a chest pain observation unit in a British hospital.

Authors:  S W Goodacre; F M Morris; S Campbell; J Arnold; K Angelini
Journal:  Emerg Med J       Date:  2002-03       Impact factor: 2.740

5.  Is a chest pain observation unit likely to be cost saving in a British hospital?

Authors:  S Goodacre; F Morris; J Arnold; K Angelini
Journal:  Emerg Med J       Date:  2001-01       Impact factor: 2.740

6.  Diagnosing acute cardiac ischemia.

Authors:  G P Young; M Rosenthal
Journal:  West J Med       Date:  1993-11

Review 7.  Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association.

Authors:  Ezra A Amsterdam; J Douglas Kirk; David A Bluemke; Deborah Diercks; Michael E Farkouh; J Lee Garvey; Michael C Kontos; James McCord; Todd D Miller; Anthony Morise; L Kristin Newby; Frederick L Ruberg; Kristine Anne Scordo; Paul D Thompson
Journal:  Circulation       Date:  2010-07-26       Impact factor: 29.690

8.  Efficacy of coronary revascularization in patients with acute chest pain managed in a chest pain unit.

Authors:  Juan Sanchis; Vicent Bodí; Julio Núñez; Luis Mainar; Eduardo Núñez; Pilar Merlos; Eva Rúmiz; Gema Miñana; Xavier Bosch; Angel Llácer
Journal:  Mayo Clin Proc       Date:  2009-04       Impact factor: 7.616

9.  Risk stratification of patients in an emergency department chest pain unit: prognostic value of exercise treadmill testing using the Duke score.

Authors:  Gregory G Johnson; Wyatt W Decker; Joseph K Lobl; Dennis A Laudon; Jennifer J Hess; Christine M Lohse; Amy L Weaver; Deepi G Goyal; Peter A Smars; Guy S Reeder
Journal:  Int J Emerg Med       Date:  2008-06-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.